SI-BONE, Inc. (SIBN) NASDAQ
14.01
+0.14(+1.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
SI-BONE, Inc.
Address
471 El Camino Real
Santa Clara, CA 95050
United States of America (the)
Phone
408 207 0700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
349
First IPO Date
October 17, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Laura A. Francis | Chief Executive Officer & Director | 1.41M | 1967 |
| Jeffrey W. Dunn | Executive Chairman | 90,000 | 1956 |
| Michael A. Pisetsky | Chief Business & Legal Affairs Officer, Secretary and General Counsel | 756,146 | 1978 |
| Anshul Maheshwari | COO & CFO | 814,039 | 1980 |
| Anthony J. Recupero | Advisor | 900,418 | 1960 |
| Daniel Joseph Cher | Senior Vice President of Clinical, Regulatory Affairs & Quality | 0 | 1965 |
| Scott A. Yerby | Senior Vice President of Engineering & Chief Technology Officer | 0 | 1968 |
| W. Carlton Reckling | Chief Medical Officer & Vice President of Medical Affairs | 0 | 1963 |
| Ian Bailey | Vice President of Product & Marketing | 0 | N/A |
| Jeffrey D. Zigler | Senior Vice President of Market Access & Reimbursement | 0 | N/A |
| Nikolas F. Kerr | Chief Commercial Officer | 0 | 1972 |
| Saqib Iqbal | Vice President of Financial Planning & Analysis and Investor Relations | 0 | N/A |
| Aimee Einstein | Vice President of People & Culture | 0 | N/A |
Description
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
